IRIS
UCCELLI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 37.779
AS - Asia 5.088
NA - Nord America 4.331
Continente sconosciuto - Info sul continente non disponibili 771
SA - Sud America 427
AF - Africa 100
OC - Oceania 10
Totale 48.506
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 36.998
US - Stati Uniti d'America 4.048
SG - Singapore 1.979
CN - Cina 1.207
VN - Vietnam 866
BD - Bangladesh 488
FR - Francia 295
BR - Brasile 258
HK - Hong Kong 183
CA - Canada 123
DE - Germania 86
FI - Finlandia 82
AR - Argentina 76
GB - Regno Unito 66
MX - Messico 57
IN - India 54
JP - Giappone 50
CH - Svizzera 42
IQ - Iraq 37
ID - Indonesia 35
NL - Olanda 32
JM - Giamaica 26
PK - Pakistan 25
ES - Italia 24
EC - Ecuador 23
ZA - Sudafrica 23
CO - Colombia 21
RU - Federazione Russa 20
UA - Ucraina 20
CR - Costa Rica 19
IE - Irlanda 17
TR - Turchia 17
VE - Venezuela 16
MA - Marocco 15
PH - Filippine 15
SA - Arabia Saudita 14
KE - Kenya 13
PL - Polonia 12
AZ - Azerbaigian 11
DZ - Algeria 11
PY - Paraguay 11
UZ - Uzbekistan 11
CL - Cile 10
JO - Giordania 10
TH - Thailandia 10
TW - Taiwan 10
GT - Guatemala 9
HN - Honduras 9
KR - Corea 9
NI - Nicaragua 9
SE - Svezia 9
TT - Trinidad e Tobago 9
AU - Australia 8
TN - Tunisia 8
BE - Belgio 7
EG - Egitto 7
MY - Malesia 7
PT - Portogallo 7
RS - Serbia 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
IL - Israele 6
LT - Lituania 6
PE - Perù 6
SI - Slovenia 6
GR - Grecia 5
SC - Seychelles 5
BH - Bahrain 4
BO - Bolivia 4
BY - Bielorussia 4
HR - Croazia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MN - Mongolia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
BB - Barbados 3
BZ - Belize 3
DK - Danimarca 3
IR - Iran 3
PR - Porto Rico 3
AL - Albania 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
HT - Haiti 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LC - Santa Lucia 2
MD - Moldavia 2
MK - Macedonia 2
MM - Myanmar 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
SX - ???statistics.table.value.countryCode.SX??? 2
Totale 47.706
Salva come PNG Salva come JPEG
Città #
Genova 19.862
Genoa 10.923
Rapallo 2.878
Vado Ligure 2.571
San Jose 1.102
Singapore 980
Ashburn 435
Ho Chi Minh City 290
Lauterbourg 269
Beijing 238
Hanoi 173
Hong Kong 170
New York 163
Santa Clara 102
Council Bluffs 90
Bordighera 86
Los Angeles 84
Helsinki 78
Rome 73
Frankfurt am Main 70
Milan 63
Buffalo 55
Chicago 49
Haiphong 44
Tokyo 44
Da Nang 40
Mexico City 37
Bar Harbor 33
Dallas 33
St Louis 33
Boardman 31
Phoenix 31
Zurich 30
Atlanta 29
São Paulo 28
Houston 26
Montreal 26
Orem 25
Naples 23
Tianjin 23
Philadelphia 22
Toronto 22
Washington 21
Bologna 19
Denver 19
Queens 19
Hải Dương 18
Kingston 18
Turin 18
Southampton 16
Baghdad 15
Brooklyn 15
Dublin 15
Florence 15
Detroit 14
Johannesburg 13
Memphis 13
Nairobi 13
San Francisco 13
San José 13
Amsterdam 12
Des Moines 12
Jacksonville 12
Phủ Lý 12
Baku 11
Brescia 11
Can Tho 11
Guangzhou 11
Thái Bình 11
Charlotte 10
City of London 10
Madrid 10
Ninh Bình 10
Tashkent 10
Amman 9
Birmingham 9
Jakarta 9
Karachi 9
Mumbai 9
Reggio Emilia 9
Bari 8
Boston 8
Chennai 8
Columbus 8
Fort Lauderdale 8
Kyiv 8
Managua 8
Miami 8
Milwaukee 8
Paris 8
Quảng Ngãi 8
Rochester 8
Stockholm 8
Vĩnh Long 8
Baltimore 7
Catania 7
Changsha 7
Cleveland 7
Dayton 7
Guatemala City 7
Totale 42.032
Salva come PNG Salva come JPEG
Nome #
C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. 286
Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS 270
Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis. 247
Finger motor performance as a new quantitative clinical endpoint in multiple sclerosis 247
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy 244
17p11.2 duplication is a common finding in sporadic cases of charcot-marie-tooth type 1 242
Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. 240
Adult stem cells for spinal cord injury: what types and how do they work? 233
Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation 233
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 226
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 224
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 222
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice 221
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. 221
Neuroprotective features of mesenchymal stem cells. 220
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 220
Association of melanoma and natalizumab therapy in the Italian MS population: a second case report. 218
Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption 215
Effect of radial shock wave therapy on pain and muscle hypertonia: a double-blind study in patients with multiple sclerosis. 212
IFN-γ orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways 212
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 208
Quantitative 3D investigation of Neuronal network in mouse spinal cord model 208
Unveiling the enigma of the CNS as a B-cell fostering environment. 207
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 207
Different MRI patterns in MS worsening after stopping fingolimod 207
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. 204
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 204
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. 204
Sirt6 regulates dendritic cell differentiation, maturation, and function 202
Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration 200
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis. 199
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 196
Hereditary motor and sensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases 196
Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling. 195
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 195
Exploring Alzheimer's disease mouse brain through X-ray phase contrast tomography: From the cell to the organ 195
Ghost spasticity in multiple sclerosis 194
The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse. 193
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. 192
Immunotherapy for neurological diseases. 192
X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model 191
Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. 191
A RCT Comparing Specific Intensive Cognitive Training to Aspecific Psychological Intervention in RRMS: The SMICT Study 191
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 190
Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction. 189
Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography 189
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 189
Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis 189
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 189
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1 188
Anti-Glutamic Acid Decarboxylase Limbic Encephalitis Without Epilepsy Evolving Into Dementia With Cerebellar Ataxia 188
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 187
Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks 186
Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors As Therapeutics: Rationales, Controversies, Clinical Experience. 186
Investigation of paroxysmal dystonia in a patient with multiple sclerosis: a transcranial magnetic stimulation study. 185
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation 182
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 182
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 181
Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. 181
Immuno-therapeutic potential of haematopoietic and mesenchymal stem cell transplantation in MS. 181
Teriflunomide treatment reduces B cells in patients with MS. 180
Neurorepair with mesenchymal stem cells: hope or hype? 179
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. 179
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. 179
Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of multiple sclerosis. 178
The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms 177
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. 177
18f-fluorodeoxyglucose positron emission tomography tracks the heterogeneous brain susceptibility to the hyperglycemia-related redox stress 177
Hypothalamic AgRP neurons control hematopoiesis and lymphopoiesis and are activated in experimental MS 176
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. 176
Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter? 176
Cingulum bundle alterations underlie subjective fatigue in multiple sclerosis 175
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 175
A case of thyroiditis during natalizumab therapy for multiple sclerosis 175
Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells. 174
CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS 174
Central and peripheral nervous system complications following allogeneic bone marrow transplantation. 173
A bridge between evidence-based laboratory diagnostics and research in neuroimmunology: why standardizations and guidelines matter. 173
Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients. 172
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 172
Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience. 171
Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy. 171
Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. 171
Human mesenchymal stem cells promote survival of T cells in a quiescent state. 171
Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis. 170
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. 170
T-cell trafficking in the central nervous system. 169
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 169
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 169
Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? 168
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 167
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients. 167
Human mesenchymal stem cells modulate B-cell functions. 167
Primary varicella zoster infection associated with fingolimod treatment. 166
Stem cells for multiple sclerosis: promises and reality. 164
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. 164
The Italian multiple sclerosis register 164
Corneal epithelial dendritic cells in patients with multiple sclerosis: An in vivo confocal microscopy study 164
Conventional perimetry, short-wavelength automated perimetry, frequency-doubling technology, and visual evoked potentials in the assessment of patients with multiple sclerosis. 164
Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases 163
Totale 19.252
Salva come PNG Salva come JPEG
Categoria #
all - tutte 155.553
article - articoli 136.312
book - libri 498
conference - conferenze 14.118
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.625
Totale 311.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.469 107 213 319 457 152 193 143 755 174 317 118 521
2022/20233.468 329 292 41 362 558 581 21 221 593 37 362 71
2023/20242.391 110 246 70 274 181 405 239 158 126 71 147 364
2024/20257.029 339 480 212 467 811 685 729 1.261 296 361 612 776
2025/202613.869 1.617 428 800 1.156 1.825 958 1.933 771 997 1.347 868 1.169
2026/20271.377 1.377 0 0 0 0 0 0 0 0 0 0 0
Totale 48.506